Back to search

Article

The Deubiquitinase USP2 Inhibits Clear Cell Renal Cell Carcinoma by Activating the p53 Signaling Pathway and Inducing Ferroptosis

2026-01-22

Abstract excerpt

<title>Abstract</title> <p>Background Clear cell renal cell carcinoma (ccRCC) remains lethal in 40% of patients because of intrinsic resistance to VEGF- and immune-targeted therapies. The deubiquitinase (DUB) family has been implicated in tumour–immune crosstalk, but a systems-level portrait and functional driver gene are still lacking. Methods Multi-cohort transcriptomic profiles (TCA-KIRC, n = 528; E-MTAB-198...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
db1aeb8c-16c0-5184-b694-8625c798ade0
DOI
10.21203/rs.3.rs-8166530/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The Deubiquitinase USP2 Inhibits Clear Cell Renal Cell Carcinoma by Activating the p53 Signaling Pathway and Inducing FerroptosisDOI 10.21203/rs.3.rs-8166530/v1
Select a neighboring publication to make it the new centre.